Detailed price information for Henry Schein Inc (HSIC-Q) from The Globe and Mail including charting and trades.

HSIC slides after Q2 EPS misses estimates by 6.8%. Revenues beat with 3.2% growth and strength across key segments.

High interest rates and inflationary pressures have hurt demand for non-urgent procedures such as orthodontic treatment and higher-end restorative dental procedures. Henry Schein, which has seen ...

Dental and medical products company Henry Schein (NASDAQ:HSIC) met Wall Street’s revenue expectations in Q2 CY2025, with ...